🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Niall C. Tebbutt

La Trobe University

ORCID: 0000-0003-2613-5168

Also affiliated with Olivia Newton-John Cancer Wellness & Research Centre, Austin Health

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study”.

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study

PLoS Medicine(2021)10.1371/journal.pmed.1003620
N/A
5.4DataRank · unranked
180 citations

Yuxuan Wang, Joshua D. Cohen, Lu Li, Wei Hong, Michael Christie +22 more

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies

International Journal of Cancer(2020)10.1002/ijc.33312
N/A
4.7DataRank · unranked
113 citations

Joshua D. Cohen, Serigne Lo, Yuxuan Wang, Lu Li, Michael Christie +23 more

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial

Cancer Chemotherapy and Pharmacology(2011)10.1007/s00280-010-1303-3
N/A
0.581DataRank · unranked
47 citations

Philip R. Clingan, Vinod Ganju, Andrew H. Strickland, Shirley S. Wong, Niall C. Tebbutt +7 more

ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.3503
N/A
0.470DataRank · unranked
22 citations

Yuxuan Wang, Jonathan M. Loree, Joshua D. Cohen, David Espinosa Espinosa, Rachel Wong +15 more

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

Journal of Clinical Oncology(2025)10.1200/jco.24.00055
N/A
0.457DataRank · unranked
20 citations

Kohei Shitara, Katrin Marie Sjoquist, Andrew Martin, Anthony Jaworski, Niall C. Tebbutt +16 more